Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
for Low-grade NMIBC
34 locations incl. Homewood
Sponsor: Tyra Biosciences, Inc
Sex: All·Age: 18+
Code: NCT06995677·Phase 2·Recruiting·Listed May 2025